ONIRIA THERAPEUTICS, S.L.
Contact information
Oniria Therapeutics
Esther Riambau, CEO
CELLEX CENTER, C/ Natzaret, 115-117
Barcelona
Barcelona
+34 620006316
Areas of activities
- A. Health Biotechnology
- Areas of activity
- Biodrugs
- Therapeutic areas
- Oncology
Commissions
Oniria Therapeutics is a biopharmaceutical company with the mission to develop drugs in the field of precision oncology and specifically focused on cancer persistence.
Oniria Therapeutics is a Spin-out of the Vall d’Hebron Institute of Oncology, the University of Barcelona and ICREA.
Products and services
At Oniria Therapeutics we translate hard-won knowledge on cancer cell resistance to advanced treatments for patients.
ONR-001, our flagship product, is a first-in-class small molecule that allosterically activates TET2, a master epigenetic enzyme, causing tumor cells to enter a dormant state and even die.
Areas of interest for future collaborations
Biomarkers, pharmaceutical companies and preclinical and clinical research services companies.